Abstract:Background: About 30% of women entering pregnancy in the US are obese. We have previously reported mitochondrial dysregulation and increased inflammation in the placentae of obese women. Vitamin D (VitD) is a major player in calcium uptake and was shown to modulate mitochondrial respiration and the immune/inflammation system. Studies show decreased VitD levels in obese individuals; however, the effect of maternal obesity on VitD metabolism and its association with placental function remains understudied. Methods: Maternal and cord blood plasma and placental samples were collected upon C-section from normal-weight (NW, body mass index [BMI]<25) and obese (OB, BMI>30) women with uncomplicated pregnancies at term. We measured 25(OH)D3 (calcidiol) levels in maternal and cord blood plasma using ELISA. We assessed the expression of CYP27B1, an activator of calcidiol, and Vitamin D receptor (VDR) in placentae from NW and OB, and women with gestational diabetes and preeclampsia. In addition, we examined the effects of VitD supplementation on mitochondrial function and inflammation in trophoblasts from NW and OB, using the Seahorse Bioanalyzer and Western blot, respectively. Results: Vitamin D levels in blood from OB but not NW women and in cord blood from babies born to NW and OB women showed a significant inverse correlation with maternal pre-pregnancy BMI (r=-0.50, p<0.1 and r=-0.55, p=0.004 respectively). Cord plasma VitD levels showed a positive correlation with placental efficiency, i.e., the ratio between fetal and placental weight, as well as with maternal blood VitD levels (r=0.69 and 0.83 respectively, p<0.00). While we found no changes in CYP27B1 in OB vs. NW women, VDR expression were decreased by 50% (p<0.03) independent of fetal sex. No changes in VDR expression relative to BMI-matched controls were observed in the placentae of women with gestational diabetes or preeclampsia. Cytotrophoblasts isolated from placentae of OB women showed a dose-dependent increase in VDR expression after 24-hour treatment with calcitriol (10 nM and 100 nM), an active form of VitD. Trophoblasts isolated from OB women and treated with calcitriol improved mitochondrial respiration (p<0.05). We also found a two-fold increase in expression of the NLRP3 inflammasome and the pro-inflammatory cytokine IL-18 in trophoblasts isolated from placentae of OB women (p<0.05), with IL-18 expression being reversed by calcitriol treatment (100 nM). Conclusions: We show that VitD deficiency is at least partially responsible for mitochondrial dysfunction and increased inflammation in the placentae of obese women. Vitamin D supplementation could be beneficial in improving placental dysfunction seen in obese women.

Vitamin D stimulates miR-26b-5p to inhibit placental COX-2 expression in preeclampsia

Vitamin D stimulates placental L-type amino acid transporter 1 (LAT1) in preeclampsia

Vitamin D decreases cell death and inflammation in human umbilical vein endothelial cells and placental explants from pregnant women with preeclampsia cultured with TNF-α

Vitamin D3 Alters Toll-like Receptor 4 Signaling in Monocytes of Pregnant Women at Risk for Preeclampsia.

Serum and Placental Interleukin-18 Are Elevated in Preeclampsia

The relationship among vitamin D, TLR4 pathway and preeclampsia

Inhibition of LAMP3 mediates the protective effect of vitamin D against hypoxia/reoxygenation in trophoblast cells

Mir-195 Modulates Oxidative Stress-Induced Apoptosis Andmitochondrial Energy Production In Human Trophoblasts Via Flavin Adenine Dinucleotide-Dependent Oxidoreductase Domain-Containing Protein 1 And Pyruvate Dehydrogenase Phosphatase Regulatory Subunit

Vitamin D Supplementation Improves Mitochondrial Function and Reduces Inflammation in Placentae of Obese Women

Testosterone Represses Estrogen Signaling by Upregulating Mir-22

MicroRNA‑144‑3p may participate in the pathogenesis of preeclampsia by targeting Cox‑2.

MiRNA‐548c‐5p downregulates inflammatory response in preeclampsia via targeting PTPRO

Downregulated Mir-195 Detected In Preeclamptic Placenta Affects Trophoblast Cell Invasion Via Modulating Actriia Expression

MicroRNA-376c Impairs Transforming Growth Factor-Β and Nodal Signaling to Promote Trophoblast Cell Proliferation and Invasion.

Microrna‑646 Inhibits Angiogenesis of Endothelial Progenitor Cells in Pre‑eclamptic Pregnancy by Targeting the VEGF‑A/HIF‑1α Axis

Vitamin D restores angiogenic balance and decreases tumor necrosis factor-α in a rat model of pre-eclampsia.

Extracellular vesicle‐derived microRNA‐18b ameliorates preeclampsia by enhancing trophoblast proliferation and migration via Notch2/TIM3/mTORC1 axis

Methylation Mediated Silencing of miR-155 Suppresses the Development of Preeclampsia In Vitro and In Vivo by Targeting FOXO3

Low Circulating Levels of Vitamin D May Contribute to the Occurrence of Preeclampsia Through Deregulation of Treg /th17 Cell Ratio.

Glucocorticoid Exposure Induces Preeclampsia Via Dampening 1,25-Dihydroxyvitamin D 3

Vitamin D Levels in Early and Middle Pregnancy and Preeclampsia, a Systematic Review and Meta-Analysis